Red X iconGreen tick iconYellow tick icon

Jo Gullam Head of Department
Senior Lecturer

MB ChB(Leic) MD(Warw) DFFP FRANZCOG MRCOG

Jo joined the department in February 2011.

Having completed her undergraduate training at Leicester, she developed an interest in research and completed her MD thesis in Preterm Labour at Warwick University.

During her postgraduate training in Obstetrics and Gynaecology, Jo developed a keen interest in high-risk obstetric care, maternal medicine and birth suite management, which remain the mainstay of her research interests and clinical practice today.

Jo is the birth suite lead obstetrician and takes an active role in clinical governance and evidence based guideline formulation.

Jo is actively involved in teaching within the department, in both the undergraduate and postgraduate training programmes. She has been the fifth year programme Convenor since 2012.

Jo is a dedicated foodie and likes nothing more than investigating what riches her adopted country has to offer.

Publications

Hughes, R. C. E., Kyle, P., Phillips, I., Florkowski, C. M., & Gullam, J. (2025). In suspected fetal growth restriction, sFlt-1/PlGF and PlGF may have value in risk stratification for preterm birth and birthweight < 3rd centile: A blinded cohort study. Australian & New Zealand Journal of Obstetrics & Gynaecology. Advance online publication. doi: 10.1111/ajo.70003 Journal - Research Article

Simões, E. A. F., Pahud, B. A., Madhi, S. A., Kampmann, B., Shittu, E., Radley, D., … Gullam, J., … on behalf of the MATISSE (Maternal Immunzation Study for Safety and Efficacy) Clinical Trial Group. (2025). Efficacy, safety, and immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) maternal respiratory syncytial virus prefusion F protein vaccine trial. Obstetrics & Gynecology, 145(2), 157-167. doi: 10.1097/aog.0000000000005816 Journal - Research Article

Hughes, R., Phillips, I., Florkowski, C. M., & Gullam, J. (2024). Could the sflt-1/PLGF ratio have added value in the detection and management of small for gestational age and fetal growth restriction? A prospective blinded observational study. Journal of Paediatrics & Child Health, 60(Suppl. 1), (pp. 41). doi: 10.1111/jpc.16526 Conference Contribution - Published proceedings: Abstract

Crowther, C. A., Ashwood, P., Middleton, P. F., McPhee, A., Tan, T., Harding, J. E., for the MAGENTA Study Group, including Austin, N., Darlow, B. A., Dixon, B., Gullam, J., Leishman, D., Dawson, P., Devenish, C., Gaerty, K., Tomlinson, P. A., & Miller, H. (2023). Prenatal intravenous magnesium at 30-34 weeks' gestation and neurodevelopmental outcomes in offspring: The MAGENTA randomized clinical trial. JAMA, 330(7), 603-614. doi: 10.1001/jama.2023.12357 Journal - Research Article

Tarnow-Mordi, W. O., Robledo, K., Marschner, I., Seidler, L., Simes, J., on behalf of the Australian Placental Transfusion Study (APTS) Childhood Follow Up Study Collaborators, including Gullam, J., Austin, N., Leishman, D., Stitely, M., & Dawson, P. (2023). To guide future practice, perinatal trials should be much larger, simpler and less fragile with close to 100% ascertainment of mortality and other key outcomes. Seminars in Perinatology, 47(5), 151789. doi: 10.1016/j.semperi.2023.151789 Journal - Research Article

Back to top